European stocks and US equity futures are on the verge of vaccination and M&A action.


Capped vials of Oxford University’s COVID-19 vaccine candidate, who resumed trials after a break last week.

Vincenzo Pinto / Agence France-Presse / Getty Images


European stocks rallied on Monday, with US equity futures driven by news of vaccine hope, mergers and acquisitions.

Stoxx Europe 600 Index SXXXP,
-0.04%
The best weekly return since the week ended August 7, rising 0.3% to about 1.7% after the end of last week.
-0.13%
0.3%, French CAC 40 PX1,
+ 0.10%
0.4%, while the FTSE 100 Index UKX,
-0.22%
Was trading flat.

Investors will hear from the Federal Reserve, the Bank of England and the Bank of Japan in the coming days for a busy weekend for central bank meetings.

Wall Street, with the Nasdaq-100 futures NQ100, was also pointing to a stronger start.
+ 1.39%
145 points or 1.3%, while the S&P 500 futures ES00,
+ 1.05%
38.95 points or 1.2%, and the Dow Jones Industrial Average futures YM100,
+ 0.80%
278 points or 1%.

That gain came in the week of losing to the Dow DJIA for Gain Street.
+ 0.47%
1.7% drop, S&P 500 SPX,
+ 0.05%
Fell 2.5% and Nasdaq COP,
-0.60%
March.1%, its worst weekly loss since the week ended March 20.

New hopes on the coronavirus vaccine also helped in a sense of improvement earlier in the week.

Pfizer Inc. Of PFE,
+ 1.17%
Chief executive officer Albert Borla said in an interview on Sunday that the drug maker should be informed that its COVID-19 vaccine candidate will be operational by the end of October – and if approved, it could be distributed in the US by the end of the year. Pfizer is partnering with German drugmaker Bioentech BNTX,
+ 6.42%
On vaccine development.

Oxford University also announced on Saturday that it would resume hearings for a coronavirus candidate developing with AstraZeneca AZN.
-0.72%.
The study was halted last week to review a “disorderly illness” in which a UK patient fell ill. Oxford University said it was considered safe to continue. Shares of AstraZeneca rose 0.5%.

U.S. Located Gilead Sciences Inc. GIDD on Sunday announced a 21 billion deal for Biotech Immunomedics Inc. IMMU has made a purchase of a key breast cancer drug maker.

Japanese technology company Softbank Group Corp. announced a 40 40 billion deal to sell chipmaker Nvidia NVDA to UK-based microprocessor designer Arm Holdings late Sunday evening.
-1.19%
For a mix of cash and stock.

Along with shares of German sector software group SAP SE SAP, the technology sector was also taken down by M&A,
-0.07%
0.3% rose and chip equipment manufacturer ASML Holding NV ASML,
+ 0.62%

ASML,
+ 0.40%
Above 0.3%.

And the race for tickets is getting excited. Software Software Group Racing Corp.
-0.57%
Microcorpt Corp., a technology giant, apparently by China’s BitDance. After MSFT’s offer was rejected, the US was instructed to handle the video sharing application.
-0.65%
But in a recent turn, Chinese state media say bitdance has also rejected Oracle.

Elsewhere, Euronext NV ENX,
-3.98%
On Monday it said it had submitted a non-binding offer to acquire Boris’ Italina from the London Stock Exchange Group plc LSE.
-1.01%.
Pan-European exchange in partnership with Italian lender Casa Deposit e Precity Equity and Intesa Sanpolo Olo SPA ISP,
-0.50%
On offer. Shares of Euronext fell 0.2% and shares of the London Stock Exchange fell 0.5%.

.